Delivery Order SPE2DB24D3013-SPE2DB25FFMML
Award Date
6/13/25
Potential Completion Date
6/16/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,982.91 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Budesonide-Formoterol 80-4.5 10.2GM, a medication used to treat respiratory conditions. The contract has an ultimate completion date of April 14, 2025 and was awarded on April 11, 2025. No set-aside designation was used for this award. Amerisourcebergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,055.96, is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a medication used to treat respiratory conditions. The contract is a firm-fixed-price delivery order with a performance period ending on May 2, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,310.40 firm fixed-price delivery order contract is for the supply of the pharmaceutical product Budesonide-Formoterol 160-4.5 10.2GM. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,310.40 firm fixed-price contract is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product. The contract has a performance period extending through May 21, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,210.56, is for the supply of Budesonide-Formoterol 80-4.5 10.2GM, a respiratory medication, with a final delivery date of December 12, 2023. The contract is structured as a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen also holds a larger Indefinite...
This is a $4,297.40 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Budesonide-Formoterol 80-4.5 10.2GM, a medication used to treat respiratory conditions. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,953.46, is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a medication used for the treatment of respiratory conditions. The contract is a firm fixed-price delivery order with a performance period that extends through May 6, 2025. This contract is not set aside for any specific...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,009.72 firm fixed-price contract is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a respiratory medication, with a performance period through April 2025. The award is not set-aside and represents an order under Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This is a $5,673.15 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a medical product, with a completion date of April 15, 2025. The award is not associated with a set-aside program. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a $1,480.28 delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the pharmaceutical product Budesonide-Formoterol 160-4.5 10.2 GM. It is a firm fixed price contract with a completion date of June 11, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a significant...